{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:06:44Z","timestamp":1792638404472,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","award":["Project No. 08-MED513-02"],"award-info":[{"award-number":["Project No. 08-MED513-02"]}],"id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00970-8","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T21:15:01Z","timestamp":1754342101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Differential effects of \u03b2-blockers nebivolol and metoprolol on mitochondrial biogenesis and antioxidant defense in angiotensin II-induced pathology in H9c2 cardiomyoblasts"],"prefix":"10.1186","volume":"26","author":[{"given":"Rukhsana","family":"Gul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Bazighifan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assim A.","family":"Alfadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"970_CR1","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","volume":"98","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, et al. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev. 2018;98:1627.","journal-title":"Physiol Rev"},{"key":"970_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jcp.29889","volume":"236","author":"Y Xu","year":"2021","unstructured":"Xu Y, Rong J, Zhang Z. The emerging role of angiotensinogen in cardiovascular diseases. J Cell Physiol. 2021;236:68\u201378.","journal-title":"J Cell Physiol"},{"key":"970_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yjmcc.2013.07.010","volume":"63","author":"J Mori","year":"2013","unstructured":"Mori J, Zhang L, Oudit GY, Lopaschuk GD. Impact of the renin\u2013angiotensin system on cardiac energy metabolism in heart failure. J Mol Cell Cardiol. 2013;63:98\u2013106.","journal-title":"J Mol Cell Cardiol"},{"key":"970_CR4","unstructured":"Singh KD, Karnik SS. Angiotensin receptors: structure, function, signaling and clinical applications. J Cell Signal. 2016;1."},{"key":"970_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1470320309347785","volume":"11","author":"CA Lemari\u00e9","year":"2010","unstructured":"Lemari\u00e9 CA, Schiffrin EL. The angiotensin II type 2 receptor in cardiovascular disease. J renin-angiotensin-aldosterone System: JRAAS. 2010;11:19\u201331.","journal-title":"J renin-angiotensin-aldosterone System: JRAAS"},{"key":"970_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/CM9.0000000000003009","volume":"137","author":"X Ouyang","year":"2024","unstructured":"Ouyang X, Chen W, Peng G, Liu H, Fan S, Li Q, et al. 1,12-cyclic apelin-12 ameliorates Ang II and Apelin-13-induced cardiac hypertrophy by reducing mitochondrial oxidative damage. Chin Med J. 2024;137:749.","journal-title":"Chin Med J"},{"key":"970_CR7","doi-asserted-by":"crossref","unstructured":"Dikalov SI, Nazarewicz RR, Bikineyeva A, Hilenski L, Lass\u00e8gue B, Griendling KK, et al. Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. 2014;20:281\u201394. https:\/\/www.liebertpub.com\/doi\/abs\/10.1089\/ars.2012.4918.","DOI":"10.1089\/ars.2012.4918"},{"key":"970_CR8","doi-asserted-by":"crossref","unstructured":"Wang L, Wu L, Du Y, Wang X, Yang B, Guo S, et al. DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives angiotensin II-induced vascular remodeling through regulating mitochondrial fragmentation. Redox Biol. 2023;67.","DOI":"10.1016\/j.redox.2023.102893"},{"key":"970_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/00005082-200509000-00010","volume":"20","author":"BA Staffileno","year":"2005","unstructured":"Staffileno BA. Treating hypertension with cardioprotective therapies: the role of ACE inhibitors, arbs, and beta-blockers. J Cardiovasc Nurs. 2005;20:354\u201364.","journal-title":"J Cardiovasc Nurs"},{"key":"970_CR10","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/S0140-6736(01)06660-0","volume":"358","author":"DJ Campbell","year":"2001","unstructured":"Campbell DJ, Aggarwal A, Esler M, Kaye D. \u03b2-blockers, angiotensin II, and ACE inhibitors in patients with heart failure. Lancet. 2001;358:1609\u201310.","journal-title":"Lancet"},{"issue":"6809","key":"970_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/35041687","volume":"408","author":"T Finkel","year":"2000","unstructured":"Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239\u201347.","journal-title":"Nature"},{"issue":"3","key":"970_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0928-4680(00)00053-5","volume":"7","author":"K Kannan","year":"2000","unstructured":"Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology. 2000;7(3):153\u201363.","journal-title":"Pathophysiology"},{"key":"970_CR13","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2217\/fca-2021-0048","volume":"17","author":"C Ferri","year":"2021","unstructured":"Ferri C. The role of nebivolol in the management of hypertensive patients: from Pharmacological profile to treatment guidelines. Future Cardiol. 2021;17:1421\u201333.","journal-title":"Future Cardiol"},{"key":"970_CR14","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.3390\/cimb44050144","volume":"44","author":"R Gul","year":"2022","unstructured":"Gul R, Alsalman N, Alfadda AA. Inhibition of eNOS partially blunts the beneficial effects of nebivolol on angiotensin II-Induced signaling in H9c2 cardiomyoblasts. Curr Issues Mol Biol. 2022;44:2139\u201352.","journal-title":"Curr Issues Mol Biol"},{"key":"970_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/jhh.2017.8","volume":"31","author":"A Coats","year":"2017","unstructured":"Coats A, Jain S. Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage. J Hum Hypertens. 2017;31:376.","journal-title":"J Hum Hypertens"},{"key":"970_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/00365513.2012.691991","volume":"72","author":"M Serg","year":"2012","unstructured":"Serg M, Kampus P, Kals J, Zagura M, Zilmer M, Zilmer K, et al. Nebivolol and metoprolol: Long-term effects on inflammation and oxidative stress in essential hypertension. Scand J Clin Lab Investig. 2012;72:427\u201332.","journal-title":"Scand J Clin Lab Investig"},{"issue":"4","key":"970_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/1753944709104496","volume":"3","author":"A Maffei","year":"2009","unstructured":"Maffei A, Lembo G. Nitric oxide mechanisms of nebivolol. Ther Adv Cardiovasc Dis. 2009;3(4):317\u201327.","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"4","key":"970_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/01.HYP.0000239207.82326.29","volume":"48","author":"M Oelze","year":"2006","unstructured":"Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U, et al. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension. 2006;48(4):677\u201384.","journal-title":"Hypertension"},{"key":"970_CR19","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1152\/ajpheart.01126.2011","volume":"302","author":"L Ma","year":"2012","unstructured":"Ma L, Gul R, Habibi J, Yang M, Pulakat L, Whalev-Connell A, et al. Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Transgenic (mRen2) rat. Am J Physiol - Heart Circ Physiol. 2012;302:2341\u201351.","journal-title":"Am J Physiol - Heart Circ Physiol"},{"key":"970_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/1470320312470580","volume":"14","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhang MS, Liu Y. Nebivolol treatment improves resistant arterial function and reduces ventricular hypertrophy and angiotensin II in spontaneously hypertension rats. JRAAS - J Renin-Angiotensin-Aldosterone Syst. 2013;14:146\u201355.","journal-title":"JRAAS - J Renin-Angiotensin-Aldosterone Syst"},{"key":"970_CR21","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/jpp\/rgab124","volume":"73","author":"R Gul","year":"2021","unstructured":"Gul R, Alsalman N, Bazighifan A, Alfadda AA. Comparative beneficial effects of nebivolol and nebivolol\/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts. J Pharm Pharmacol. 2021;73:1520\u20139.","journal-title":"J Pharm Pharmacol"},{"key":"970_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbrc.2013.07.055","volume":"438","author":"C Huang","year":"2013","unstructured":"Huang C, Chen D, Xie Q, Yang Y, Shen W. Nebivolol stimulates mitochondrial biogenesis in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2013;438:211\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"970_CR23","unstructured":"Morris J, Awosika AO, Dunham A. xPharm: The comprehensive pharmacology reference. Metoprolol. 2024:1\u20137."},{"key":"970_CR24","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/j.jacc.2021.07.065","volume":"78","author":"AM Dybro","year":"2021","unstructured":"Dybro AM, Rasmussen TB, Nielsen RR, Andersen MJ, Jensen MK, Poulsen SH. Randomized trial of Metoprolol in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2021;78:2505\u201317.","journal-title":"J Am Coll Cardiol"},{"key":"970_CR25","doi-asserted-by":"crossref","unstructured":"Giurdanella G, Longo A, Distefano A, Olivieri M, Cristaldi M, Cosentino A, et al. The anti-inflammatory effect of the \u03b21-adrenergic receptor antagonist metoprolol on high glucose treated human microvascular retinal endothelial cells. Cells. 2021;11:51.","DOI":"10.3390\/cells11010051"},{"key":"970_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.yjmcc.2011.05.012","volume":"51","author":"Y Fang","year":"2011","unstructured":"Fang Y, Nicol L, Harouki N, Monteil C, Wecker D, Debunne M, et al. Improvement of left ventricular diastolic function induced by \u03b2-blockade: a comparison between nebivolol and Metoprolol. J Mol Cell Cardiol. 2011;51:168\u201376.","journal-title":"J Mol Cell Cardiol"},{"key":"970_CR27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jacc.2014.11.050","volume":"65","author":"F Perros","year":"2015","unstructured":"Perros F, Ranchoux B, Izikki M, Bentebbal S, Happ\u00e9 C, Antigny F, et al. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension. J Am Coll Cardiol. 2015;65:668\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"970_CR28","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/antiox12040877","volume":"12","author":"R Gul","year":"2023","unstructured":"Gul R, Dar MA, Nawaz S, Alfadda AA. Protective effects of nanoceria against mitochondrial dysfunction and angiotensin II-Induced hypertrophy in H9c2 cardiomyoblasts. Antioxidants. 2023;12:877.","journal-title":"Antioxidants"},{"issue":"4","key":"970_CR29","doi-asserted-by":"publisher","first-page":"H901","DOI":"10.1152\/ajpheart.00250.2011","volume":"302","author":"R Gul","year":"2012","unstructured":"Gul R, Shawl AI, Kim SH, Kim UH. Cooperative interaction between reactive oxygen species and Ca2\u2009+\u2009signals contributes to angiotensin II-induced hypertrophy in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol. 2012;302(4):H901\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"970_CR30","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1089\/ars.2012.4588","volume":"19","author":"D Zablocki","year":"2013","unstructured":"Zablocki D, Sadoshima J. Angiotensin II and oxidative stress in the failing heart. Antioxid Redox Signal. 2013;19(10):1095\u2013109.","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"970_CR31","doi-asserted-by":"publisher","first-page":"H1426","DOI":"10.1152\/ajpheart.00772.2018","volume":"316","author":"N Escobales","year":"2019","unstructured":"Escobales N, Nu\u00f1ez RE, Javadov S. Mitochondrial angiotensin receptors and cardioprotective pathways. Am J Physiol Heart Circ Physiol. 2019;316(6):H1426\u201338.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"970_CR32","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/oby.21227","volume":"23","author":"R Gul","year":"2015","unstructured":"Gul R, Mahmood A, Luck C, Lum-Naihe K, Alfadda AA, Speth RC, et al. Regulation of cardiac miR-208a, an inducer of obesity, by Rapamycin and nebivolol. Obesity. 2015;23:2251\u20139.","journal-title":"Obesity"},{"key":"970_CR33","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1089\/ars.2012.4777","volume":"19","author":"SB Ong","year":"2013","unstructured":"Ong SB, Hall AR, Hausenloy DJ. Mitochondrial dynamics in cardiovascular health and disease. Antioxid Redox Signal. 2013;19:400.","journal-title":"Antioxid Redox Signal"},{"key":"970_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/07853890.2017.1417631","volume":"50","author":"DA Chistiakov","year":"2018","unstructured":"Chistiakov DA, Shkurat TP, Melnichenko AA, Grechko AV, Orekhov AN. The role of mitochondrial dysfunction in cardiovascular disease: a brief review. Ann Med. 2018;50:121\u20137.","journal-title":"Ann Med"},{"key":"970_CR35","doi-asserted-by":"crossref","unstructured":"Dikalov SI, Nazarewicz RR. Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease. 2013;19:1085\u201394. https:\/\/www.liebertpub.com\/doi\/abs\/10.1089\/ars.2012.4604.","DOI":"10.1089\/ars.2012.4604"},{"key":"970_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2018.04.041","volume":"274","author":"GT do Vale","year":"2018","unstructured":"do Vale GT, Simplicio JA, Gonzaga NA, Yokota R, Ribeiro AA, Casarini DE, et al. Nebivolol prevents vascular oxidative stress and hypertension in rats chronically treated with ethanol. Atherosclerosis. 2018;274:67\u201376.","journal-title":"Atherosclerosis"},{"key":"970_CR37","doi-asserted-by":"crossref","unstructured":"Zhang L, Wuri J, An L, Liu X, Wu Y, Hu H, et al. Metoprolol attenuates intracerebral hemorrhage-induced cardiac damage by suppression of sympathetic overactivity in mice. Auton Neuroscience: Basic Clin. 2021;234.","DOI":"10.1016\/j.autneu.2021.102832"},{"key":"970_CR38","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1007\/s00210-024-02990-3","volume":"397","author":"O Unal","year":"2024","unstructured":"Unal O, Erzurumlu Y, Asci H, Gunduru Acar B, Bedir M, Ozmen O. Nebivolol protects the liver against lipopolysaccharide-induced oxidative stress, inflammation, and Endoplasmic reticulum-related apoptosis through Chop and Bip\/GRP78 signaling. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:5899\u2013907.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"970_CR39","first-page":"2518","volume":"13","author":"Y Fan","year":"2021","unstructured":"Fan Y, Jin L, Wu Y, Fan Y, Wei Q. Effects of Metoprolol on serum inflammatory factors and myocardial ischemia in rats modeled with coronary heart disease. Am J Translational Res. 2021;13:2518.","journal-title":"Am J Translational Res"},{"key":"970_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/FJC.0000000000000647","volume":"73","author":"I Ozakca","year":"2019","unstructured":"Ozakca I. Antihypertrophic effects of nebivolol on neonatal cardiomyocyte hypertrophy models. J Cardiovasc Pharmacol. 2019;73:155\u201364.","journal-title":"J Cardiovasc Pharmacol"},{"key":"970_CR41","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.25122\/jml-2023-0090","volume":"16","author":"H Al-Amir","year":"2023","unstructured":"Al-Amir H, Janabi A, Hadi NR. Ameliorative effect of nebivolol in doxorubicin-induced cardiotoxicity. J Med Life. 2023;16:1357.","journal-title":"J Med Life"},{"key":"970_CR42","doi-asserted-by":"publisher","first-page":"435733","DOI":"10.3389\/fgene.2019.00435","volume":"10","author":"AP Gureev","year":"2019","unstructured":"Gureev AP, Shaforostova EA, Popov VN. Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1\u03b1 signaling pathways. Front Genet. 2019;10:435733.","journal-title":"Front Genet"},{"issue":"2","key":"970_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/cvr\/cvq250","volume":"88","author":"VB Pillai","year":"2010","unstructured":"Pillai VB, Sundaresan NR, Jeevanandam V, Gupta MP. Mitochondrial SIRT3 and heart disease. Cardiovasc Res. 2010;88(2):250\u20136.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"970_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.yexcr.2016.07.006","volume":"347","author":"Z Yue","year":"2016","unstructured":"Yue Z, Ma Y, You J, Li Z, Ding Y, He P, et al. NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy. Exp Cell Res. 2016;347(2):261\u201373.","journal-title":"Exp Cell Res"},{"issue":"5","key":"970_CR45","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.18632\/aging.102862","volume":"12","author":"X Feng","year":"2020","unstructured":"Feng X, Wang Y, Chen W, Xu S, Li L, Geng Y, et al. SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity. Aging. 2020;12(5):4178\u201392.","journal-title":"Aging"},{"key":"970_CR46","doi-asserted-by":"crossref","unstructured":"Tokuyama T, Yanagi S. Role of Mitochondrial Dynamics in Heart Diseases. Genes. 2023;14:1876.","DOI":"10.3390\/genes14101876"},{"issue":"6","key":"970_CR47","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1152\/japplphysiol.00898.2018","volume":"126","author":"KAS Silva","year":"2019","unstructured":"Silva KAS, Ghiarone T, Schreiber K, Grant D, White T, Frisard MI, et al. Angiotensin II suppresses autophagy and disrupts ultrastructural morphology and function of mitochondria in mouse skeletal muscle. J Appl Physiol (1985). 2019;126(6):1550\u201362.","journal-title":"J Appl Physiol (1985)"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00970-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:42:05Z","timestamp":1757349725000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00970-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["970"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00970-8","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}